Browse studies

Find your next paid study

1 recruiting study matching your filters

A Multicenter Phase II Study of Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

This is a multicenter, non-randomized, open-label, phase II study evaluating blinatumomab administered subcutaneously in adult subjects with CD19+ MPAL. This t…

CD19 PositiveMixed Phenotype Acute Leukemia (MPAL)

West Virginia UniversityNCT07222579